Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This product is a multi-ingredient nutraceutical formulation developed and manufactured by Saltvae Pharmaceuticals. It combines several key compounds intended to support joint health and cartilage maintenance. Glucosamine and chondroitin sulfate are essential structural components of glycosaminoglycans found in joint cartilage, while methylsulfonylmethane (MSM) serves as an organic sulfur donor necessary for connective tissue integrity. The addition of Vitamin C (ascorbic acid) and Vitamin E (tocopherol) provides antioxidant protection against oxidative stress in joint tissues and supports collagen synthesis. It is marketed as an oral tablet for the management of joint-related conditions such as osteoarthritis and general joint wear.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glucosamine + Chondroitin Sulfate + Methylsulfonylmethane + Vitamin C + Vitamin E.